PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 23, 2026Journal of Crohn s and Colitis0 citations

N09 Association between the clinical activity of Ulcerative Colitis and Inadequate protein intake: a cross-sectional study.

View Full Paper
VMV M Mendoza MartinezRVR Baños VazquezMCM A Santoyo Chávez

Key Points

  • To examine the relationship between protein intake and clinical activity in ulcerative colitis patients.
  • Included patients with ulcerative colitis
  • Assessed disease activity using modified Truelove and Witts criteria
  • Evaluated protein intake with 24-hour dietary recall
  • Determined muscle function using dynamometry
  • Calculated appendicular lean mass and its height-adjusted index using DXA
  • 47% of patients were clinically active, 53% in remission
  • Active patients had a higher frequency of inadequate protein intake (44% vs 14%)
  • Low protein intake was linked to clinical activity with an odds ratio of 3.1
  • Clinical activity predicted lower ALMI in women, not associated with grip strength
  • Sarcopenia prevalence was 13% in the population

Abstract

Abstract Background In Ulcerative Colitis (UC), loss of muscle mass has been associated with high disease activity and worse clinical prognosis1. Measures such as appendicular lean mass (ALM) have been used and its height-adjusted index (ALMI), obtained through dual-energy X-ray absorptiometry (DXA), are validated and accepted markers for assessing muscle status, as well as for evaluating muscle function using dynamometry. Linked to muscle mass, Protein intake has been identified as the primary nutrient for maintaining a positive nitrogen balance and preventing sarcopenia2. The RDA for protein is 0.8-1g/kg/day, which is the minimum intake necessary to avoid muscle loss2. However, in patients with active UC, it is recommended to increase the intake to 1.2-1.5g/kg/day3. Aim: To assess whether total protein intake is associated with clinical activity and decreases ALMI. Methods Patients with UC were included. Disease activity was determined using the modified Truelove and Witts criteria. Protein intake was assessed by a 24-hour dietary recall and analyzed with the EvalFinut software. Adequate intake was determinate as ≥1g/kg intake in patients in remission and as ≥1.2g/kg in patients with UC activity. Muscle function was determined using dynamometry, with cutoff points of 16 kg for women and 27 kg for men. ALM was estimated using DXA, and ALMI was calculated. Cutoff points for low lean mass were 5.5 kg/m² in women and 7 kg/m² in men4. The Mann-Whitney U test was used to assess differences between patients with activity and in remission. Odds ratios (OR) were calculated to determine the risk association between inadequate protein intake with clinical activity. Results A total of 53 patients were included, of whom 47% were clinically active and 53% in remission. Active patients showed a higher frequency of inadequate protein intake compared to those in remission (44% vs 14%) and presented with lower ALMI in women but not in men (table 1). Patients with low protein intake were associated with clinical activity, with an OR of 3.1 (95% CI, 1.1–8.4; p = 0.018), but not associated with lower grip strength (p = 0.461). On the other hand, clinical activity, and not low protein intake, was associated with greater likelihood of having decreased ALMI, with an OR of 1.8 (95% CI, 1.1–3.2; p = 0.044). The prevalence of sarcopenia was 13% of this population. Conclusion Inadequate protein intake is associated with clinical activity of UC, and clinical activity is associated with a lower amount of ALMI in women. There were no differences in grip strength between patients according to their activity level; however, follow-up will be needed to determine if those with low ALMI and low protein intake develop sarcopenia. References: 1. Zhang T, Ding C, Xie T, et al. Skeletal muscle depletion correlates with disease activity in ulcerative colitis and is reversed after colectomy. Clin Nutr. Dec 2017;36(6):1586-1592. doi:10.1016/j.clnu.2016.10.004 2. Baum JI, Wolfe RR. The Link between Dietary Protein Intake, Skeletal Muscle Function and Health in Older Adults. Healthcare (Basel). Jul 9 2015;3(3):529-43. doi:10.3390/healthcare3030529 3. Bischoff SC, Bager P, Escher J, et al. ESPEN guideline on Clinical Nutrition in inflammatory bowel disease. Clin Nutr. Mar 2023;42(3):352-379. doi:10.1016/j.clnu.2022.12.004 4. Arnal-Gomez A, Cebria IIMA, Tomas JM, et al. Using the Updated EWGSOP2 Definition in Diagnosing Sarcopenia in Spanish Older Adults: Clinical Approach. J Clin Med. Mar 2 2021;10(5)doi:10.3390/jcm10051018 Conflict of interest: Mendoza Martinez, Viridiana Montsserrat: No conflict of interest Baños Vazquez, Roberto: No conflict of interest Santoyo Chávez, Martha Alison: No conflict of interest Rivera, Ernestina: No conflict of interest De Leon Rendon, Jorge Luis: No conflict of interest López-González, Desirée: No conflict of interest Almiray-Soto, Alma Lidia: No conflict of interest Bueno Hernández, Nallely: No conflict of interest

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Martinez et al. (2026) studied this question.

synapsesocial.com/papers/69730ed4c8125b09b0d1eaf0https://doi.org/10.1093/ecco-jcc/jjaf231.1541
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1P1201Parameters of sarcopenia associated with the activity of the UC2026
  2. 2P1066Ultra-processed food intake independently predicts pre-sarcopenia in patients with inflammatory bowel disease in remission2026
  3. 3P1200Body composition parameters as predictors of clinical activity in patients with active Ulcerative Colitis2026
  4. 4P0355Prevalence of malnutrition and sarcopenia in hospitalized patients with inflammatory bowel diseases: a multimodal cross-sectional study2026
  5. 5P0222Determinants of Sarcopenia in Crohn’s Disease: Effects of Short Bowel Syndrome and Protein Intake2026